Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan K Shields

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
Antimicrobial Agents and Chemotherapy|May 28, 2026
Evaluation of combination therapy duration for endocarditis secondary to EnterobacteralesSunish Shah, Jake Smith, Brandon J Smith, et al.
Open Forum Infectious Diseases|March 24, 2026
Implementation of an Early Transition to Oral Antibiotics for Patients With Nonstaphylococcal Bacteremia via Real-Time Stewardship InterventionTyler Tate, Brandon J Smith, J Alex Viehman, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2026
Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infectionsSunish Shah, Rachel V Marini, Ryan K Shields, et al.
Journal of Chemotherapy (Florence, Italy)|November 22, 2021
Hydrolytic activity of KPC-producing <i>Klebsiella pneumoniae</i> clinical isolatesVincent H Tam, Cole S Hudson, Paul R Merlau, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniaeRyan K Shields, Cornelius J Clancy, Ellen G Press, et al.
Infection|March 27, 2025
Clinical and microbiologic outcomes of Stenotrophomonas maltophilia bloodstream infectionsSunish Shah, Brianne Slaven, Lloyd G Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2025
Translating PK-PD principles into improved methodology for clinical trials which compare intermittent with prolonged infusion of beta-lactam antibioticsAlwin M Tilanus, Ryan K Shields, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicansRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Diagnostic Microbiology and Infectious Disease|December 23, 2019
Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime-avibactam resistance emerged are not hypermutatorsKevin M Squires, M Hong Nguyen, Ryan K Shields, et al.
Pharmacotherapy|December 1, 2010
Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitisKathleen R Sheridan, Brian A Potoski, Ryan K Shields, et al.
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|May 28, 2026
Evaluation of combination therapy duration for endocarditis secondary to EnterobacteralesSunish Shah, Jake Smith, Brandon J Smith, et al.
Open Forum Infectious Diseases|March 24, 2026
Implementation of an Early Transition to Oral Antibiotics for Patients With Nonstaphylococcal Bacteremia via Real-Time Stewardship InterventionTyler Tate, Brandon J Smith, J Alex Viehman, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2026
Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infectionsSunish Shah, Rachel V Marini, Ryan K Shields, et al.
Journal of Chemotherapy (Florence, Italy)|November 22, 2021
Hydrolytic activity of KPC-producing <i>Klebsiella pneumoniae</i> clinical isolatesVincent H Tam, Cole S Hudson, Paul R Merlau, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniaeRyan K Shields, Cornelius J Clancy, Ellen G Press, et al.
Infection|March 27, 2025
Clinical and microbiologic outcomes of Stenotrophomonas maltophilia bloodstream infectionsSunish Shah, Brianne Slaven, Lloyd G Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2025
Translating PK-PD principles into improved methodology for clinical trials which compare intermittent with prolonged infusion of beta-lactam antibioticsAlwin M Tilanus, Ryan K Shields, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicansRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Diagnostic Microbiology and Infectious Disease|December 23, 2019
Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime-avibactam resistance emerged are not hypermutatorsKevin M Squires, M Hong Nguyen, Ryan K Shields, et al.
Pharmacotherapy|December 1, 2010
Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitisKathleen R Sheridan, Brian A Potoski, Ryan K Shields, et al.
Pageof 20